» Articles » PMID: 18546622

Role of P53 and Rb in Ovarian Cancer

Overview
Date 2008 Jun 13
PMID 18546622
Citations 31
Authors
Affiliations
Soon will be listed here.
Citing Articles

Aggressive Serous Carcinomas of the Female Reproductive Tract: Cancer-Prone Cell States and Genetic Drivers.

Phuong D, Pirtz M, Ralston C, Cosgrove B, Schimenti J, Flesken-Nikitin A Cancers (Basel). 2025; 17(4).

PMID: 40002199 PMC: 11852459. DOI: 10.3390/cancers17040604.


Human papillomavirus infection of the fallopian tube as a potential risk factor for epithelial ovarian cancer.

Paradowska E, Hareza D, Kania K, Jarych D, Wilczynski M, Malinowski A Sci Rep. 2024; 14(1):21602.

PMID: 39284893 PMC: 11405690. DOI: 10.1038/s41598-024-72814-0.


Advances in understanding the molecular mechanisms of borderline ovarian tumors.

Chen S, Huang L, Liang M, Xie Y, Zhou Z, Ke Y Front Mol Biosci. 2024; 11:1429852.

PMID: 39281319 PMC: 11392903. DOI: 10.3389/fmolb.2024.1429852.


Bioinformatics analysis proposes a possible role for long noncoding RNA MIR17HG in retinoblastoma.

Wang Z, Liang X, Yi G, Wu T, Sun Y, Zhang Z Cancer Rep (Hoboken). 2024; 7(2):e1933.

PMID: 38321787 PMC: 10864729. DOI: 10.1002/cnr2.1933.


Triple Reporter Assay: A Non-Overlapping Luciferase Assay for the Measurement of Complex Macromolecular Regulation in Cancer Cells Using a New Mushroom Luciferase-Luciferin Pair.

Mujawar A, Phadte P, Palkina K, Markina N, Mohammad A, Thakur B Sensors (Basel). 2023; 23(17).

PMID: 37687774 PMC: 10490530. DOI: 10.3390/s23177313.


References
1.
McCluskey L, Chen C, Delgadillo E, Felix J, Muderspach L, Dubeau L . Differences in p16 gene methylation and expression in benign and malignant ovarian tumors. Gynecol Oncol. 1999; 72(1):87-92. DOI: 10.1006/gyno.1998.5235. View

2.
Bali A, OBrien P, Edwards L, Sutherland R, Hacker N, Henshall S . Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer. Clin Cancer Res. 2004; 10(15):5168-77. DOI: 10.1158/1078-0432.CCR-03-0751. View

3.
Szotek P, Pieretti-Vanmarcke R, Masiakos P, Dinulescu D, Connolly D, Foster R . Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci U S A. 2006; 103(30):11154-9. PMC: 1544057. DOI: 10.1073/pnas.0603672103. View

4.
Shih I, Kurman R . Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol. 2004; 164(5):1511-8. PMC: 1615664. DOI: 10.1016/s0002-9440(10)63708-x. View

5.
Huh M, Parker M, Scime A, Parks R, Rudnicki M . Rb is required for progression through myogenic differentiation but not maintenance of terminal differentiation. J Cell Biol. 2004; 166(6):865-76. PMC: 2172111. DOI: 10.1083/jcb.200403004. View